Perry Fell, MBA, PhD
Dr. Perry Fell is an experienced researcher who has had success as a scientist-founder and scientist-CEO. Perry brings with him vast experience and wisdom in overcoming both scientific and business challenges in the life sciences. He was the Director of Molecular Immunology at Bristol-Myers Squibb Pharmaceutical Research Institute from 1989 to 1997. In 1997, he co-founded Seattle Genetics, and served as the CEO from start-up through IPO. At Seattle Genetics, Dr. Fell and his team pioneered the use of antibody-drug conjugates for the treatment of various cancers. He subsequently served as the Chairman of the Board of Seattle Genetics from 2002-2004. From 2004-2009, Perry was the Chairman, CEO, and President of NanoString Technologies. Perry is currently the Chairman of Prevencio, a company dedicated to bringing new diagnostics to the ER, cardiology clinics, and clinical laboratories. Perry was the first member of Recursion's Business Advisory Panel, joining in May 2014, and accepted a position as an independent Board Member in May 2015.